Thursday, March 13, 2014
Gist: Learning About Gist: A Mysterious Rare Cancer
GIST- Gastrointestinal Stromal Tumor is a rare disorder that in the past has been rapidly fatal. But researchers armed with the latest scientific breakthroughs are making great strides against this deadly cancer. In this program, we take you inside the laboratories to see how clinical trials are helping scientists better understand GIST and other cancers. And we'll hear from patients who are living with GIST about how they stay upbeat in the face of such a formidable foe.
Monday, March 17, 2014
Advances In Treating Colon Cancer with Surgery
Colon cancer is the third most common cancer diagnosed in both men and women. But it's also a cancer that can often be prevented by early and appropriate screening. Also, regular screening-when people are in their 40's - 50's-can often find colon cancer early, when it is most likely to be curable. In this program we look at treating colon and rectal cancer and focus on a surgical advance that may be helping patients recover faster. It's minimally invasive colon surgery. Unlike the traditional operations with large incisions and longer recovery times - the minimally invasive procedure involves smaller incisions -and a much shorter recovery. This can help reduce both the physical and emotional impact on patients' lives. Plus if the cancer is found early enough-this minimally invasive procedure may be all the treatment they need. We'll also see why the comprehensive care model works so well in colon & rectal cancer by treating the patient as well as the cancer.
Thursday, March 20, 2014
Preventing Deep Vein Thrombosis & Pulmonary Embolism: Dangerous Blood Clots
Deep Vein Thrombosis (DVT) is a condition where blood clots form in the deep veins of the legs. When parts of these clots break off they can travel to the lungs and cause a potentially fatal condition called Pulmonary Embolism or PE. These dangerous and deadly blood clots can form in anyone, but hospitalized patients, those who are on long airplane flights, or anyone who is sedentary for any length of time can be at risk. In this program, we'll see what can be done to prevent both DVT and PE. We'll also see how scientists working with public health experts are finding ways to help people lower their risks of both deep vein thrombosis and pulmonary embolism.
Monday, March 24, 2014
Epilepsy: Solving The Mystery
Epilepsy is a brain disorder that can range from mild to severe. It can even be life-threatening. Essentially, anything that can disturb the normal pattern of neuron activities in the brain can result in epilepsy. Having a seizure does not automatically determine one has epilepsy, but when two or more seizures occur epilepsy is often the cause. In this program we seek to explore how patients can work with their medical teams to manage this mysterious disorder. We hear about the treatments that can help patients get control of the disease-and the lifestyle factors that can help reduce the stress that often accompanies living with epilepsy.
Thursday, March 27, 2014
New Ways to Manage Mds
Myelodysplastic Syndromes-MDS-is the name given to a group of little-known conditions where the bone marrow does not produce enough normal blood cells for the body to function properly. This can result in the crushing fatigue that is characteristic of anemia and increased infections and bleeding because of low white cells and fewer platelets. The only way to cure MDS is with a stem cell transplant-but since the disease is frequently diagnosed in elderly people-a stem cell transplant isn't generally regarded as safe for that patient population. Over the last several years researchers have come forward with new, less intense treatments for this condition. In this program, we travel to Boston & Martha's Vineyard, Mass, Dusseldorf Germany and Florence Italy to hear about the latest treatments that can help many patients with MDS-even those who are in their 80s or 90s.
Monday, March 31, 2014
Treating Non-Hodgkin's Lymphoma
Lymphoma is the most common blood cancer in the United States with approximately 75,000 new cases diagnosed every year. Doctors categorize most lymphomas as either Hodgkin's or Non-Hodgkin's Lymphoma-and Non-Hodgkin's Lymphoma-or NHL is by far the most common. In fact, according to the Leukemia & Lymphoma Society Non-Hodgkin lymphoma is the most common cancer of the lymphatic system. And since the early 1970's, incidence rates for NHL have nearly doubled. But Non-Hodgkin's Lymphoma is not a single disease. Rather it is a group of several closely related cancers broadly divided into two categories: B-cell Lymphoma & T-cell Lymphoma. In this program we take viewers inside the hospital to the medical practices of two acclaimed researchers and clinicians who are fighting the NHL battle with their patients. We hear how treatments for these diseases have changed recently-and listen as two patients detail their struggles- and their successes --as they work to gain victory over these diseases.